EA
Ejaz Ahmad Rabbani
About Ejaz Ahmad Rabbani
Data last updated:
Ejaz Ahmad Rabbani is a Director at Cardimes Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Cardimes Pharmaceuticals Private Limited reported revenue of ₹1.64 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2021 | 2021 | ₹1.64 Cr (FY 2025) | Active |
Board colleagues of Ejaz Ahmad Rabbani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hafsa Khatoon | 09469398 | Cardimes Pharmaceuticals Private Limited | Director |
| Md Mohsin Hashmi | 09047521 | Cardimes Pharmaceuticals Private Limited | Managing Director |
| Mohammad Shakir | 09047522 | Cardimes Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ejaz Ahmad Rabbani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ejaz Ahmad Rabbani
Ejaz Ahmad Rabbani currently holds 1 directorship: Cardimes Pharmaceuticals Private Limited (Director, since 01 Feb 2021, revenue ₹1.64 Cr (FY 2025)).
Ejaz Ahmad Rabbani was first appointed on 01 Feb 2021 as Director at Cardimes Pharmaceuticals Private Limited.
The current boards of Ejaz Ahmad Rabbani's companies include Hafsa Khatoon (Cardimes Pharmaceuticals Private Limited), Md Mohsin Hashmi (Cardimes Pharmaceuticals Private Limited), Mohammad Shakir (Cardimes Pharmaceuticals Private Limited).